Trial intelligence / Profile preview

Meloxicam injection for postoperative abdominal pain

CTR20210567Phase 2Completed

Sponsor
Hengrui Therapeutics
Start
Mar 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of meloxicam in postoperative pain, sponsored by Hengrui Therapeutics. Started Mar 2021; status: completed.

02

Drugs

meloxicam
03

Conditions

postoperative pain

Beyond the preview

Go deeper on CTR20210567.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20210567.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call